Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.

The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, A. L., Dowsett, M., Smith, I. E., Jeffcoate, S. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1983
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011397/
https://www.ncbi.nlm.nih.gov/pubmed/6221746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011397/
https://www.ncbi.nlm.nih.gov/pubmed/6221746

Ejemplares similares